A lymphocyte clonal assay developed to quantitate in vivo somatic cell mutations at the hypoxanthine-guanine phosphoribosyltransferase locus was modified in order to study resistance to methotrexate. Even though nucleoside-free culture conditions were used methotrexate was not lethal to lymphocytes plated into micro-wells at >102cells/well. HPLC 
The modulating effects of nucleosides on tumour growth inhibition by antifolates have been recognised for many years. A combination of thymidine (TdR) and hypoxanthine (Hx) prevents methotrexate-induced lethality in normal and malignant cells in vitro (Howell et al., 1981; Taylor & Tattersall, 1981) . In the human leukaemic cell line CCRF-CEM, TdR or Hx alone partially protect from methotrexate (MTX) induced growth inhibition (Taylor & Tattersall, 1981) . In addition, exogenous purines can reduce or potentiate methotrexate cytotoxicity in a variety of mammalian cell lines, depending in part on the methotrexate concentration (Taylor et al., 1982) . Moreover differences in nucleoside concentrations in commercial sources of calf and horse serum can significantly influence the outcome of studies of methotrexate interaction with other drugs (Piper et al., 1983) . For all these reasons the use of dialysed serum, and TdR and purine free media has recently been advocated to study MTX-induced cytotoxicity in clonogenic assays (Sobrero & Bertino, 1986) .
Clinical dogma maintains that acquired resistance to cytotoxic drug treatment is extremely rare in normal cells but a frequent development in tumour cells. The biological basis for this apparent difference in frequency of development of resistant phenotype between normal and tumour cells has not been defined. However a clonal assay for human peripheral blood lymphocytes (PBLs) has now been established and somatic cell mutations at the hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8.) locus on the Xchromosome have been measured using the purine analogue 6-thioguanine (6-TG) as the selecting agent (Morley et al., 1985; Albertini et al., 1982 (Taswell, 1981) . The frequency of spontaneous mutation to resistance to 15,pM 6-TG was calculated from the ratio of the cloning efficiencies in the presence and absence of 6-TG.
Bromodeoxyuridine (BrUdR) incorporation assay The thymidine analogue BrUdR was added to each well to give a final concentration of lOpM, 24h prior to harvest (after 2, 5, 8 and 13 days incubation). Well cultures were resuspended by aspiration with a 26G needle and syringe, and the contents of duplicate wells were pooled and centrifuged (200 g) and 200 p1 supernatant removed. The remaining contents were resuspended and cytocentrifuged (Shandon Elliott Cytospin; Cheshire, UK) onto glass slides. Slides were fixed immediately in methanol:acetic acid (3:1) and stored at room temperature prior to staining. Nuclei that had incorporated BrUdR were visualised using immunoperoxidase amplification of a mouse monoclonal antibody binding to BrUdR-substituted DNA, resulting in deposition of brown pigment over positive cells (deFazio, 1987) . Haematoxylin was used as a counterstain. Where possible over 400 nuclei were counted per slide.
HPLC analysis of well culture supernatants Purine bases and nucleosides from deproteinised (Centricon 30 microconcentrators, Amicon Scientific, Australia) well supernatants were separated using modifications of Agarwal's methods (Agarwal, 1982 A guard column (30 by 4.6mm ID) packed with lOpm LiChrosorb was used before an RP-18, lOpm column (250 by 4.5mm ID; Brownlee Lab Inc. Santa Clara CA). Initially the eluents were lOmMKH2PO4, pH4.9 (solvent A) and 30% methanol in 10mM KH2PO4 (solvent B) and 40 p1 aliquots of unknowns and standards were injected. A gradient (2 min of 10% B in A followed by 10-30% B in A over 15 min) separated peaks which were identified by their absorbance ratios and retention times by comparison with pure nucleoside and purine base standards. This method allowed quantitative separation (in order of increasing retention time) of uric acid 3.05, cytosine 3.49, Hx 4.23, uridine 4.68, xanthine (X) 4.88, inosine 9.41, guanosine 10.41, deoxyinosine 11.34, TdR 13.67 and adenosine 20.73. The identification of the TdR peak was confirmed by enzymic peak-shift techniques using thymidine phosphorylase and an isocratic run (5% methanol in solvent A) for greater efficiency. Similarly the presence of Hx and X was confirmed by digestion with xanthine oxidase using an isocratic run (3% methanol in solvent A).
Results
Data obtained using the above culture conditions on 25 blood donations from 16 normal donors were comparable with those published by others (Albertini et al., 1982; Morley et al., 1983) . PBL cloning efficiencies in the absence of drugs varied from 20.6-53.75%, and the frequency of mutant cells resistant to 15.0,pM 6-thioguanine ranged from P.BX 10-cut-r1.eX 1 N-5.
PBLs cultured in NM in the presence of MTX 0.01-100 pM and 104 feeder cells/well showed reduction of colony size rather than cytotoxicity. Figure 1 demonstrates (Figure 2a) . However in the presence of feeder cells MTXinduced cell death by day 14 was reduced in both NM and DM cultures (Figure 2a) . In a similar experiment where BrUdR was added to wells 24 h prior to harvest, it was apparent that even on the 5th day in 100 pM MTX _ 45% of cells were incorporating BrUdR ie synthesising DNA. Cycling cells were observed whether cultured in NM or DM and with or without feeder cells. By the 13th day in culture a small percentage (5-16%) of cells incorporated BrUdR during the 24 h pulse period.
Feeder cells were necessary for growth with low initial target cell numbers in either DM or NM (Figure 2b) . When the initial PBL number was reduced to < 102 cells/well, growth in DM cultures was completely inhibited by MTX (OOpM) in contrast to NM cultures (Figure 1 and 2b) and X (Figure 3a,b) . TdR was not detected until the day 8 harvest when it was found in all wells (0.3-1.8uM) whether or not feeders were present or the cultures were in DM (Figure 3a,b (Figure 4 ). Neither TdR nor Hx at these concentrations affected PBL growth in the absence of MTX (Figure 4 ), nor individually altered MTX toxicity.
Discussion
We have successfully established the assay for in vivo somatic cell mutations developed independently by both Morley et al. (1983 Morley et al. ( , 1985 and Albertini et al. (1982 Albertini et al. ( , 1985 using 6-TG as the selection agent for mutations at the hypoxanthineguanine phosphoribosyltransferase locus. However, when MTX was used as the selecting agent in the assay, cytotoxicity was not observed (Figure 1 ). MTX was most growth inhibitory to cells plated at high initial densities (104 cells/well) even though the cell growth rate was markedly less in the corresponding control wells than in controls plated at lower densities. Wells inoculated with 102 cells initially in MTX increased their cell number 10-fold over the incubation period. Clearly MTX cytotoxicity was modulated by some aspect of the culture conditions and the initial target cell numbers were a crucial determining factor. The lowered growth rate in control cultures plated at higher initial densities indicates that the levels of nutrients or crowding or some other factor affected growth. The number of viable cells remaining in all wells after extended exposure to high MTX concentrations could not be attributed to mutation to resistance alone. Modulation of MTX cytotoxicity by exogenous thymidine and purines in mammalian cells is well known. Thymidine and purine free RPMI-1640 in combination with dialysed FBS (DM) eliminated all non-cellular sources of these nucleosides and bases, however growth equivalent to that in NM was still observed in the presence of MTX if high plating densities were used (Figure 2a) Our HPLC data demonstrate that with time Hx and TdR appeared at micromolar levels in DM culture supernatants (Figure 3a, b) . The appearance of these purines and pyrimidines may be attributed to the catabolism of nucleic acid from dead and dying cells. When feeder cells were omitted from higher density DM cultures, Hx and TdR still appeared in the medium albeit at lower levels. This observation is consistent with the hypothesis that dying target cells release metabolites that rescue viable target cells from antifolate cytotoxicity and growth inhibition. Our data (Figure 4 ) clearly demonstrate that micromolar levels of TdR and Hx prevent methotrexate cytotoxicity in this lymphocyte clonal assay, and therefore the cells remaining at the end of the culture period are PBLs with very efficient nucleoside and base salvage mechanisms. These salvage mechanisms must be blocked if this assay is to be used to screen for MTX resistance due to other mechanisms. A drug known to inhibit nucleoside transport, such as dipyridamole may be of use. Sobrero & Bertino (1986) been extablished. However similar problems have been reported with the measurement of methotrexate resistance using soft agar cloning techniques (Cole & Arlett, 1976 complicating factor in the in vitro chemosensitivity measurements in human tumour stem cell assays. Metabolites from dying cells may also modulate the cytotoxicity of other antimetabolites, such as 5-fluorouracil and cytosine arabinoside when similar culture conditions are utilised. The possibility must be considered that regional variations in nucleoside and base concentrations in vivo may modulate antimetabolite cytotoxicity. It has been demonstrated that extracellular nucleoside and base concentrations in bone marrow for instance are substantially greater than in peripheral plasma . Purines at these levels have been shown to modulate MTX toxicity in culture (Taylor et al., 1982) . The extracellular purine status within solid tumours is not well defined but it is known that hypoxia, which commonly occurs in solid tumours, increases plasma Hx levels (Saugstad, 1975) . Cell death in avascular areas may also raise the nucleoside and base concentrations within the tumour microenvironment. For all these reasons these metabolites may be important determinants of antimetabolite toxicity in normal and malignant tissues in vivo.
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